OT-730 Uses, Dosage, Side Effects and more
OT-730 is under investigation in clinical trial NCT00753168 (Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma).
| Trade Name | OT-730 |
| Generic | OT-730 |
| Type | |
| Formula | C25H36N2O8 |
| Weight | Average: 492.569 Monoisotopic: 492.247166127 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
